Follow The Filings

Insider trades

Stock that executives, directors and 10% owners bought and sold on the open market, from the Form 4s they file with the SEC within two business days. Grants, option exercises and shares sold to cover taxes are left out.

4,792 companies covered Latest filing Oct 6 History loaded for 0 of 4,792

  • $1.4B bought by 293 insiders at 194 companies
  • $6.3B sold by 282 insiders outside a trading plan
  • $3.3B sold by 627 insiders under 10b5-1 plans
  • 10 companies where two or more insiders bought (30 days)

Biggest buys

Past month · by insider, all their filings added up

  1. LENLennar Corporation
    Berkshire Hathaway Inc.10% owner · +1 joint filer
    7,502,276 shares at $79.35 Sep 17–Oct 2 · 4 filings 3 superinvestors bought in Q2
    $595M
  2. KODKodiak Sciences Inc
    Baker Bros. Advisors LPDirector · +5 joint filers
    1,941,755 shares at $80.85 Sep 28–29 · 3 filings +11% to stake 1 superinvestor sold in Q2
    $157M
  3. CRBGCorebridge Financial Inc.
    Life Insurance Co Nippon10% owner
    3,623,743 shares at $34.22 Sep 16–Oct 2 · 13 filings +2.9% to stake 2 superinvestors bought in Q2
    $124M
  4. GPIGroup 1 Automotive, Inc.
    Conifer Management, L.L.C.10% owner
    465,650 shares at $246.24 Sep 17–30 · 3 filings +32% to stake 2 superinvestors bought in Q2
    $115M
  5. UUUUniversal Safety Products, Inc.
    Milton C Ault IIIDirector
    33,734 shares at $2,741.80 Sep 17–30 · 4 filings
    $92.5M
  6. GMEGameStop Corporation
    Ryan CohenCEO
    2,300,680 shares at $23.49 Sep 21–Oct 2 · 3 filings +5.8% to stake
    $54M
  7. GRABGrab Holdings Limited
    Anthony Ping Yeow TanCEO
    10.4M shares at $2.89 Sep 21 +2415% to stake
    $29.9M
  8. GSATGlobalstar, Inc.
    James Monroe IIIDirector
    361,600 shares at $82.52 Sep 18 +775% to stake
    $29.8M
  9. COURCoursera, Inc.
    Pale Fire Capital SE10% owner · +4 joint filers
    2,332,742 shares at $4.87 Sep 25–29 +8.8% to stake
    $11.4M
  10. CVCapsoVision, Inc.
    Eliyahou Et Al Harari10% owner
    1,757,469 shares at $5.69 Sep 18 New stake
    $10M

Biggest sales

Past month · by insider, all their filings added up · planned sales marked

  1. FANGDiamondback Energy, Inc.
    SGF FANG Holdings, LP10% owner · +1 joint filer
    18.2M shares at $205.26 Sep 16 · 2 filings 22% of stake
    $3.7B
  2. IHTInnSuites Hospitality Trust
    Marc E BergEVP & Secretary/Treasurer
    16,000 shares at $22,593.60 Sep 17 33% of stake Planned sale (10b5-1)
    $361M
  3. NVDANvidia Corporation Com
    Mark A StevensDirector
    1,366,000 shares at $219.73 Sep 18 59% of stake
    $300M
  4. AVGOBroadcom Inc.
    Henry SamueliDirector
    702,190 shares at $356.04 Sep 23 1.9% of stake Planned sale (10b5-1)
    $250M
  5. UMCUnited Microelectronics Corporation
    Chitung LiuCFO
    1,600,000 shares at $143.00 Sep 16–17 38% of stake
    $229M
  6. THTarget Hospitality Corp.
    TDR Capital II Investments LP10% owner · +9 joint filers
    11M shares at $18.40 Oct 1 40% of stake
    $202M
  7. AURAurora Innovation, Inc.
    Uber Technologies, Inc10% owner
    29.4M shares at $6.21 Sep 15 16% of stake
    $182M
  8. ESTCElastic N.V.
    Steven SchuurmanDirector
    1,500,000 shares at $90.13 Oct 5 25% of stake
    $135M
  9. CRWDCrowdStrike Holdings, Inc.
    Burt W. PodbereCFO
    513,882 shares at $259.91 Sep 21–24 · 2 filings Part planned (10b5-1)
    $134M
  10. MEDPMedpace Holdings, Inc.
    August J. TroendleCEO
    201,669 shares at $624.08 Sep 15–30 · 6 filings 37% of stake
    $126M

Cluster buying

Companies where two or more insiders bought on the open market in the last 30 days · most buyers first

  1. SPGSimon Property Group, Inc. 11 insiders · $461K

    Reuben S Leibowitz Director, Larry C Glasscock Director, Daniel C. Smith Director, Gary M Rodkin Director, +7 more

    Latest buy Sep 30
  2. FULH. B. Fuller Company 7 insiders · $621K

    Daniel L Florness Director, Srilata Zaheer Director, Charles T Lauber Director, Trangsrud Teresa J Rasmussen Director, +3 more

    Latest buy Sep 30 1 superinvestor bought in Q2
  3. ATCHAtlasClear Holdings, Inc. 5 insiders · $163K

    Thomas Jon Hammond Director, Sandip I Patel CFO, John Martin Schaible Chair, David Craig Ridenhour President, +1 more

    Latest buy Sep 25 3 executives
  4. RGCORGC Resources Inc. 5 insiders · $85K

    John B Williamson III Director, Robert B Johnston Director, Paul W Nester CEO, Lawrence T. Oliver Senior VP and Secretary, +1 more

    Latest buy Oct 1 3 executives
  5. MPBMid Penn Bancorp 5 insiders · $25K

    Matthew G De Soto Director, Albert J. Evans Director, Kimberly J Brumbaugh Director, Theodore W Mowery Director, +1 more

    Latest buy Sep 30
  6. SBLKStar Bulk Carriers Corp. 4 insiders · $4.2M

    Alexandros Pappas Insider, Raffaele Zagari Director, Nikolaos Reskos COO, Charis Plakantonaki Chief Strategy Officer

    Latest buy Sep 15 2 executives 1 superinvestor bought in Q2
  7. PRHIPresurance Holdings, Inc. 4 insiders · $200K

    Joseph D Sarafa Director, Brian J Roney CEO, Isolde O'Hanlon Director, Harold J Meloche CFO

    Latest buy Sep 30 2 executives
  8. ANIXAnixa Biosciences, Inc. 4 insiders · $181K

    Lewis H Titterton Jr. Director, Amit Kumar CEO, Michael Catelani CFO, Arnold M Baskies Director

    Latest buy Sep 30 2 executives
  9. WVVIWillamette Valley Vineyards, Inc. 4 insiders · $52K

    Michael Jordan Osborn CEO, Gregory William Voorhies Director, Chris Riccardi Director, James W Bernau President

    Latest buy Oct 5 2 executives
  10. AUBNAuburn National Bancorporation, Inc. 4 insiders · $5,441

    J Tutt Barrett Director, David E Housel Director, William F Ham Jr. Director, Shannon O'Donnell Senior Vice President

    Latest buy Sep 30 1 executive

All insider trades

Newest filings first · one row per filing · every open-market buy and sale

  1. Joseph F Hanna Director
    MGRCMcGrath RentCorp
    Planned sale
    $863K 7,500 shares at $115.04 4.9% of stake
    Traded Oct 1 Filed Oct 2
  2. Foundation Fighting Blindness Retinal Degeneration Fund Director · +1 joint filer
    IRDOpus Genetics, Inc.
    Sale
    $2.8M 556,000 shares at $4.96 15% of stake
    Traded Sep 30 Filed Oct 2
  3. Randolph Altschuler Director
    XMTRXometry, Inc.
    Planned sale
    $1M 10,000 shares at $104.04 1.8% of stake
    Traded Oct 1 Filed Oct 2
  4. Francis S Soistman Jr. Director
    EHTHeHealth, Inc.
    Planned sale
    $28K 40,612 shares at $0.6900 4% of stake
    Traded Oct 1–2 Filed Oct 2
  5. Ita M Brennan Director
    PLPlanet Labs PBC
    Planned sale
    $187K 11,500 shares at $16.30 4.4% of stake
    Traded Oct 1 Filed Oct 2
  6. Frances Arnold Director
    GOOGLAlphabet Inc., Class A
    Planned sale
    $28K 83 shares at $340.45 0.4% of stake
    Traded Sep 30 Filed Oct 2
  7. Gregory Baszucki Director
    RBLXRoblox Corporation
    Planned sale
    $714K 16,666 shares at $42.87 1.3% of stake
    Traded Oct 1 Filed Oct 2
  8. Richard A. Heyman Director
    ORICOric Pharmaceuticals, Inc.
    Planned sale
    $87K 6,700 shares at $12.91
    Traded Oct 1 Filed Oct 2
  9. John Wendell Thompson Director
    RBRKRubrik, Inc.
    Planned sale
    $1.6M 13,500 shares at $115.69
    Traded Oct 1 Filed Oct 2
  10. Hollings Renton Director
    ANABAnaptysBio, Inc.
    Planned sale
    $249K 5,000 shares at $49.87 31% of stake
    Traded Oct 1 Filed Oct 2
  11. Glenn Steele Jr. MD PHD Director
    PTCTPTC Therapeutics, Inc.
    Planned sale
    $782K 12,000 shares at $65.16 35% of stake
    Traded Sep 30 Filed Oct 2
  12. Jeffrey Jacob Raider Director
    WRBYWarby Parker Inc.
    Planned sale
    $416K 15,000 shares at $27.70 3.4% of stake
    Traded Oct 1 Filed Oct 2
  13. Joseph Stilwell Director · +5 joint filers
    WHLRWheeler Real Estate Investment Trust, Inc.
    Sale
    $15 5 shares at $3.03 <0.1% of stake
    Traded Sep 30 Filed Oct 2
  14. Matthew L. Posard Director
    HALOHalozyme Therapeutics, Inc.
    Planned sale
    $568K 5,230 shares at $108.54 8.9% of stake
    Traded Oct 1 Filed Oct 2
  15. Daniel Freifeld Director
    MRTMarti Technologies, Inc.
    Sale
    $2.6M 1,350,000 shares at $1.91 18% of stake
    Traded May 18–Sep 9 Filed Oct 2
  16. Michael F Angelo Director
    VHCVirnetX Holding Corp
    Planned sale
    $10K 1,000 shares at $10.26 3.4% of stake
    Traded Sep 30 Filed Oct 2
  17. Paul Cahill Sciarra Director
    JOBYJoby Aviation, Inc.
    Planned sale
    $381K 62,500 shares at $6.09 0.1% of stake
    Traded Oct 2 Filed Oct 2
  18. Ulrike Helfer Director
    GSLGlobal Ship Lease, Inc.
    Sale
    $179K 4,000 shares at $44.82 32% of stake
    Traded Sep 30 Filed Oct 2
  19. Jennifer Tejada Chair
    PDPagerDuty, Inc.
    Planned sale
    $1.6M 107,000 shares at $15.11 6.4% of stake
    Traded Sep 30 Filed Oct 2
  20. Watkin Phoebe L. Yang Director
    DOCSDoximity, Inc.
    Planned sale
    $34K 1,290 shares at $26.71 5% of stake
    Traded Sep 30 Filed Oct 2
  21. Sherri Goodman Director
    LTBRLightbridge Corporation
    Planned sale
    $7,020 1,116 shares at $6.29 1.6% of stake
    Traded Oct 1 Filed Oct 2
  22. Thomas E Chorman Director
    SXIStandex International Corporation
    Planned sale
    $14K 50 shares at $271.39 0.4% of stake
    Traded Oct 1 Filed Oct 2
  23. William S. Creekmuir Director
    FLXSFlexsteel Industries, Inc.
    Sale
    $101K 1,250 shares at $81.13 6.2% of stake
    Traded Sep 14–15 Filed Oct 2
  24. Martin Tuchman Director
    BPRNPrinceton Bancorp, Inc.
    Sale
    $95K 3,000 shares at $31.72 0.5% of stake
    Traded Apr 3, 2023 Filed Oct 2
  25. Mercedes Johnson Director
    TERTeradyne, Inc.
    Planned sale
    $67K 167 shares at $402.90 2.6% of stake
    Traded Oct 1 Filed Oct 2
  26. May Yihong Wu Director
    NOAHNoah Holdings Ltd.
    Sale
    $126K 16,000 shares at $7.89 44% of stake
    Traded Sep 29–30 Filed Oct 2
  27. Kang Jyh Lee Director
    PLABPhotronics, Inc.
    Sale
    $308K 10,000 shares at $30.75 2.9% of stake
    Traded Sep 29 Filed Oct 1
  28. Anthony Mathew Eisen Director
    XYZBlock, Inc.
    Planned sale
    $1.3M 18,000 shares at $73.76 1.3% of stake
    Traded Sep 29–Oct 1 Filed Oct 1
  29. William Sydney Fisher Director
    GAPGap, Inc. (The)
    Sale
    $1.5M 66,344 shares at $23.06 0.4% of stake
    Traded Sep 30 Filed Oct 1
  30. David Brian Miller Director
    ONTOOnto Innovation Inc.
    Planned sale
    $600K 2,000 shares at $300.00 16% of stake
    Traded Sep 29 Filed Oct 1
  31. Nicole Lamb-Hale Director
    FRTFederal Realty Investment Trust
    Sale
    $163K 1,500 shares at $108.89 25% of stake
    Traded Sep 30 Filed Oct 1
  32. William B Gordon Director
    TTWOTake-Two Interactive Software, Inc.
    Planned sale
    $2M 10,000 shares at $202.39 18% of stake
    Traded Sep 29 Filed Oct 1
  33. Richard D Gebert Director
    IRTIndependence Realty Trust, Inc.
    Planned sale
    $7,235 500 shares at $14.47 1.2% of stake
    Traded Oct 1 Filed Oct 1
  34. Corazon (Corsee) D. Sanders Director
    LEGNLegend Biotech Corporation
    Sale
    $259K 27,370 shares at $9.46 34% of stake
    Traded Sep 29 Filed Oct 1
  35. Ned S Holmes Director
    PBProsperity Bancshares, Inc.
    Planned sale
    $73K 1,100 shares at $66.58
    Traded Sep 30 Filed Oct 1
  36. Margaret Knight Director
    EXODExodus Movement, Inc.
    Planned sale
    $956 135 shares at $7.08 1.1% of stake
    Traded Oct 1 Filed Oct 1
  37. John Wilson Boynton IV Director
    NBISNebius Group N.V.
    Planned sale
    $12K 50 shares at $235.01 <0.1% of stake
    Traded Sep 29 Filed Oct 1
  38. Daniel R Chard Director
    MEDMedifast Inc.
    Planned sale
    $226K 19,089 shares at $11.85 13% of stake
    Traded Sep 28–29 Filed Sep 30
  39. Charles D Montgomery Director
    APTAlpha Pro Tech, Ltd.
    Sale
    $111K 21,943 shares at $5.04 47% of stake
    Traded Sep 28 Filed Sep 30
  40. Charles D Montgomery Director
    APTAlpha Pro Tech, Ltd.
    Sale
    $152K 23,886 shares at $6.38 28% of stake
    Traded May 11–12 Filed Sep 30
  41. Donna Millar Director
    APTAlpha Pro Tech, Ltd.
    Sale
    $35K 6,971 shares at $5.04 0.5% of stake
    Traded Sep 28 Filed Sep 30
  42. Xiaodong Wang Director
    ONCBeOne Medicines Ltd.
    Planned sale
    $11.3M 31,028 shares at $364.79 100% of stake
    Traded Sep 28 Filed Sep 30
  43. Theresa Yanofsky Director
    CGCCanopy Growth Corporation
    Sale
    $14K 14,920 shares at $0.9300 10% of stake
    Traded Sep 28 Filed Sep 30
  44. David Angelo Lazzarato Director
    CGCCanopy Growth Corporation
    Sale
    $21K 22,380 shares at $0.9300 11% of stake
    Traded Sep 28 Filed Sep 30
  45. Joseph Bayern Director
    CGCCanopy Growth Corporation
    Sale
    $2,869 3,096 shares at $0.9300 2.1% of stake
    Traded Sep 28 Filed Sep 30
  46. Benjamin Silbermann Director
    PINSPinterest, Inc.
    Planned sale
    $1.7M 93,750 shares at $18.53 100% of stake
    Traded Sep 29–30 Filed Sep 30
  47. Keith R Larson Director
    NWPXNWPX Infrastructure, Inc.
    Planned sale
    $102K 1,000 shares at $102.20 6.4% of stake
    Traded Sep 28 Filed Sep 30
  48. David S Marriott Director
    MARMarriott International, Inc.
    Sale
    $1.2M 3,500 shares at $352.09 1.2% of stake
    Traded Sep 25 Filed Sep 29

About this data

  • Officers, directors and anyone owning more than 10% of a company must report a trade in its stock on a Form 4 within two business days. We read each filing from SEC EDGAR and link to it on every row.
  • Only open-market purchases and sales of common stock count here. Stock grants, option exercises, gifts and shares withheld or sold to pay taxes on vesting awards are not decisions to buy or sell, so they are left out.
  • A planned sale was made under a Rule 10b5-1 trading plan, which the insider set up months in advance. Many executives sell this way on a schedule, so a planned sale says less than one made on the day.
  • Values are shares times the price reported. When a filing amends an earlier one, the amended trades replace the originals. Related owners (a fund and its manager) who report the same trade separately are shown once.
  • We cover the 4,792 US companies on our earnings calendar, with a year of history. The superinvestor notes count the featured 13F managers who added or cut the stock in their latest quarter.